Reader TTS

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans and we are optimistic about our

agenda. We are taking in another installment in our “Let’s-see-them-before-they-die” concert series and plan to take the short person in search of the Great Pumpkin. We will, of course,

also take some naps. But what about you? Those of you with yards could get some exercise by raking leaves or, if you prefer, ignore the mess and take a drive to watch the leaves fall

elsewhere. Any distraction from the current state of affairs may be a good thing. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon … THE ONTARIO GOVERNMENT IS

INVESTIGATING ALLEGATIONS THAT TEVA PHARMACEUTICALS (TEVA) OFFERED PHARMACIES “ILLEGAL” PAYMENTS TO STOCK ITS OPIOID MEDICATIONS FENTANYL AND OXYCODONE, The Toronto Star reports. The

newspaper obtained emails showing a Teva corporate accounts manager offering to pay an Ontario pharmacy group a rate of 15 percent of the drug price if it stocked the prescription opioids.

LOS ANGELES CITY ATTORNEY MIKE FEUER HAS LAUNCHED AN INVESTIGATION INTO AVANIR PHARMACEUTICALS (AVNR) FOR AGGRESSIVELY TARGETING NURSING HOME RESIDENTS with a drug called Nuedexta that may

be unnecessary or unsafe for this population, CNN reports. The network recently disclosed inappropriate and potentially fraudulent use of the medication, in some cases by doctors who have

received tens of thousands of dollars to help promote the drug. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE —

PLUS IN-DEPTH ANALYSIS, NEWSLETTERS, PREMIUM EVENTS, AND NEWS ALERTS. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to

STAT+. Subscribe